MedPath
NMPA Approval

Infliximab for Injection

国药准字S20210039

September 24, 2021

Drug Information

注射用英夫利西单抗

安佰特

注射剂

100mg/瓶

生物制品

September 24, 2021

Company Information

Applicant Company

浙江省杭州市富阳区胥口镇海正路8号

Manufacturing Company

浙江省杭州市富阳区胥口镇海正路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用英夫利西单抗 - NMPA 批准文号 | MedPath